Investors

Presentations & Videos

Presentations & Videos

2020

For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 (0) 400 009 774 E: ronn.bechler@marketeye.com.au

Zelira Therapeutics Investor Presentation

Zelira Therapeutics Chairman Osagie Imasogie and Global CEO Dr Oludare Odumosu deliver a slide presentation and answer investor questions as part of a business update.

Zelira AGM Presentation January 2022

CEO Oludare Odumosu and Chairman Osagie Imasogie presentation at the Zelira AGM 2022

Zelira AGM Presentation January 2022

A Global Biopharmaceutical Company Developing and Marketing Clinically Validated Cannabinoid-Based Medicines

Zelira Therapeutics’ commercialisation program

Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive

Channel 9 News Perth

Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain

Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics Investor Slide Deck

Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial

Some excerpt

Investor Presentation – Non-Deal Roadshow
Proactive Interview – Zelira Therapeutics on its acquisition with Ilera
CFN Media Interviews Zelda Therapeutics at New West Summit
Zelda Therapeutics – Investor Teleconference, 16 October 2019
Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.
Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’
AGM Presentation – Non-deal Roadshow
AGM Presentation
Investor Presentation
Investor Presentation
Investor Presentation

Start typing and press Enter to search

Shopping Cart